Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference

June 3, 2024

https://www.globenewswire.com/news-release/2024/06/03/2892092/0/en/Entrada-Therapeutics-to-Present-at-Goldman-Sachs-45th-Annual-Global-Healthcare-Conference.html

BOSTON, June 03, 2024 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq:TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets long considered inaccessible. The Company today announced that Dipal Doshi, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL. The fireside chat will be held on Monday, June 10, 2024, at 4:00 p.m. Eastern Time.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.